Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients

Clinical trial NCT00251004 · COMPLETED

Trial details

NCT number: NCT00251004
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Transplantation Graft Rejection

Start date: 2005-10-01
Primary completion: 2009-08-01
Enrollment: 833

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.